Symptomatic elevations of lactic acid and their response to treatment manipulation in human immunodeficiency virus-infected persons: a case series.
暂无分享,去创建一个
[1] B. Mégarbane,et al. [Lactic acidosis and multi-organ failure secondary to anti-retroviral therapy in HIV-infected patients]. , 1999, Presse medicale.
[2] C. Schramm,et al. Thiamine for the treatment of nucleoside analogue-induced severe lactic acidosis. , 1999, European journal of anaesthesiology.
[3] P. Roy,et al. Severe lactic acidosis induced by nucleoside analogues in an HIV-infected man. , 1999, Annals of emergency medicine.
[4] E. Grimsley,et al. Zidovudine-associated type B lactic acidosis and hepatic steatosis in an HIV-infected patient. , 1999, Southern medical journal.
[5] E. Zafrani,et al. Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion. , 1999, Journal of hepatology.
[6] J. Smeitink,et al. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway , 1998, AIDS.
[7] Lenzo Np,et al. Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: a case report. , 1997 .
[8] J. Shapiro,et al. Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: report of two patients and review of the literature. , 1997, Critical care medicine.
[9] N. Lenzo,et al. Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: a case report. , 1997, AIDS.
[10] J. Olano,et al. Massive hepatic steatosis and lactic acidosis in a patient with AIDS who was receiving zidovudine. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] J. L. Martin,et al. Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis , 1994, Antimicrobial Agents and Chemotherapy.
[12] C. Tsai,et al. Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides , 1994, Antimicrobial Agents and Chemotherapy.
[13] R. Gherardi,et al. Optimal handling of blood samples for routine measurement of lactate and pyruvate. , 1994, Archives of pathology & laboratory medicine.
[14] M. Chevallier,et al. Fulminant hepatitis with severe lactate acidosis in HIV‐infected patients on didanosine therapy , 1994, Journal of internal medicine.
[15] K. K. Lai,et al. Fulminant hepatic failure associated with 2',3'-dideoxyinosine (ddI). , 1991, Annals of internal medicine.
[16] J H Wilmore,et al. Anaerobic threshold and maximal aerobic power for three modes of exercise. , 1976, Journal of applied physiology.